The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold or perhaps give companies lead time to substitute other ingredients.
The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold or perhaps give companies lead time to substitute other ingredients.
It is harmless. But moving it to the inactive ingredients will still leave many of them without a decongestant and they’ll have to change all of their packaging/marketing. The other ingredients are usually for fever reduction or cough suppression. It would be a waste of their money to keep a useless ingredient.